With the recent recognition of non-coding RNAs (ncRNAs) flanking many genes 1-5 , a central issue is to obtain a full understanding of their potential roles in regulated gene transcription programmes, possibly through different mechanisms 6-12 . Here we show that an RNA-binding protein, TLS (for translocated in liposarcoma), serves as a key transcriptional regulatory sensor of DNA damage signals that, on the basis of its allosteric modulation by RNA, specifically binds to and inhibits CREB-binding protein (CBP) and p300 histone acetyltransferase activities on a repressed gene target, cyclin D1 (CCND1) in human cell lines. Recruitment of TLS to the CCND1 promoter to cause gene-specific repression is directed by single-stranded, low-copy-number ncRNA transcripts tethered to the 59 regulatory regions of CCND1 that are induced in response to DNA damage signals. Our data suggest that signalinduced ncRNAs localized to regulatory regions of transcription units can act cooperatively as selective ligands, recruiting and modulating the activities of distinct classes of RNA-binding coregulators in response to specific signals, providing an unexpected ncRNA/RNA-binding protein-based strategy to integrate transcriptional programmes.
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These findings were extended by demonstrating that recombinant TLS could bind to CBP ( Fig. 1d ) and strongly inhibited CBP HAT activity on core histones (Fig. 1e, lane 3) . Glutathione S-transferase (GST)-TLS partly inhibited the acetylation of CBP itself, but not that of p53 (Fig. 1e , lane 6), suggesting that TLS selectively inhibits the ability of the acetylated CBP to transfer acetate to specific substrates. TLS also bound to p300 and TIP60 (for Tat-interacting protein 60) with similar affinities, but not to p/CAF (for p300/CBP-associated factor) ( Fig. 1d and Supplementary Fig. 2c ). GST-TLS inhibited the HAT activity of p300 ( Fig. 2b ) but not that of TIP60 ( Supplementary  Fig. 2d , e). TLS was also able to inhibit the acetylation by CBP of histones in nucleosomes prepared from HeLa cell nuclei ( Supplementary Fig. 2f ). TLS and its two related proteins EWS (for Ewing's sarcoma) and TAFII68 (for TATA-box-binding-proteinassociated factor 68) (ref. 23 ) all proved to be present in highmolecular-mass fractions that correlate with activity that is inhibitory of CBP HAT (Fig. 1b , bottom, and Supplementary Fig. 3a ). Similarly, EWS and TAFII68 were found to bind to CBP and TIP60 but not to p/CAF ( Supplementary Fig. 3b, d) , and exerted inhibitory effects on HAT activities of CBP and p300 ( Supplementary Fig. 3c ; data not shown). TLS interacted with several regions of CBP, with the region including the p160-interaction domain 24 (residues 1892-2441) serving as the most effective interaction domain ( Supplementary Fig. 4 ). Pull-down HAT assays showed that recombinant TLS had no effect on the HAT activity of the isolated CBP_HAT region ( Supplementary Fig. 2g ), suggesting that the weak interaction of TLS with the CBP HAT domain (residues 1099-1877) is not sufficient for inhibitory effects towards HAT.
We next tested whether the inhibition of CBP HAT by TLS was RNA dependent. A synthetic RNA containing the consensus sequence GGUG (referred to below as the GGUG oligonucleotide) bound to TLS; mutations of GGUG to CCUC caused impaired binding 25 ( Supplementary Fig. 5a ). Treatment of TLS, EWS or TAFII68 with RNase A resulted in dissociation from p300 and CBP but not from TIP60 ( Fig. 2a ; Supplementary Fig. 5e , lanes 3-4; Supplementary Fig. 5f ; Supplementary Fig. 6 ). Consistently, the inhibitory activity of GST-TLS on p300 HAT was abolished when GST-TLS was pretreated with the Ca 21 -dependent micrococcal nuclease (MNase) but not with DNase I (Fig. 2b ). After blocking of MNase activity with EGTA, addition of the GGUG oligonucleotide, but not the CCUC oligonucleotide, restored the inhibitory effect of TLS on p300 HAT activity ( Fig. 2b) .
Interaction studies showed that the carboxy terminus of TLS (residues 211-526; 373-526 interacted with the GGUG oligonucleotide ( Supplementary Fig. 5b ), whereas the amino terminus (residues 1-211) interacted with CBP ( Supplementary Fig. 5c ).The N terminus of TLS was found to possess a detectably stronger inhibitory activity towards CBP HAT than did the full-length TLS ( Supplementary Fig.  5d ), and its interaction with CBP was not disrupted by treatment with RNase A ( Supplementary Fig. 5e , lanes 1 and 2). Furthermore, the N terminus of TLS was capable of interacting with the C terminus of TLS (residues 373-526) in a manner that was inhibited by GGUG oligonucleotide in a dose-dependent manner (Fig. 2c ), whereas the GGUG oligonucleotide enhanced the binding of TLS to p300 and CBP ( Fig. 2d ; data not shown). Partial proteolysis assays revealed that the GGUG oligonucleotide enhanced the cleavage of TLS ( Supplementary Fig. 5g ). Taken together, our findings suggest that an RNA-dependent allosteric modification of TLS relieves the inhibitory function of the C terminus of TLS, allowing the N terminus of TLS to bind to CBP and p300 and to regulate the HAT activity allosterically.
CCND1, a cell cycle regulator repressed by DNA damage signals 26 , is an endogenous CREB target gene 27 and is induced in RAW264.7 cells by forskolin ( Fig. 3a ). Specific murine TLS short interfering RNA (siRNA; in this case referred to as siTLS) caused a marked increase in both basal and forskolin-stimulated CCND1 mRNA levels in these cells ( Fig. 3a and Supplementary Fig. 7a ). Overexpression of human TLS could overcome the effect of siTLS ( Supplementary Fig.  7c ). Knockdown of p300 and CBP with specific siRNAs significantly decreased the acetylation of histone H3 on Lys 9 and Lys 14 (AcH3-K9K14) on the CCND1 promoter detected by chromatin immunoprecipitation (ChIP) and CCND1 mRNA levels (Fig. 3b , c, and Supplementary Fig. 7a ), indicating required functions of these coactivators on this gene. Wild-type CBP, but not a HAT-mutant CBP 28 , upregulated CCND1 promoter activity ( Supplementary Fig. 7b ), suggesting that CCND1 expression is dependent on the HAT function of CBP. When RAW264.7 cells were cultured with carrier (without forskolin) in serum-starved medium, both p300 and TLS were bound to the CCND1 promoter at the CRE site ( Fig. 3d ). Treatment with forskolin caused TLS to be dismissed from the CCND1 promoter ( Fig. 3d) , despite a slight increase in total cellular levels of TLS ( Supplementary  Fig. 8a) . In contrast, p300 remained bound (Fig. 3d ). ChIP analysis revealed hyperacetylation of histone (AcH3-K9K14) on the CCND1 promoter after treatment with forskolin ( Fig. 3d ) or knockdown of TLS (Fig. 3e ). Taken together, our data suggest that TLS acts as a repressor of CCND1. However, we did not observe binding of TLS on all CREB targets ( Supplementary Fig. 8b ), suggesting that the negative regulation of CREB target genes by TLS is gene-specific.
In searching for endogenous regulatory RNAs, we took advantage of the fact that the expression of CCND1 is downregulated in response to DNA damage signals such as those arising from ionizing radiation 29 , correlated with decreased histone acetylation ( Supplementary Fig. 9a, b ). We considered previously unrecognized local transcripts, generated upstream of the CCND1 promoter, as possible candidates. As shown in Fig. 4a , first-strand synthesis was performed with random primers, followed by real-time PCR with a series of validated specific primer pairs that showed similar amplification efficiencies on genomic DNA templates, spanning from 22008 to 2162 base pairs upstream of the established CCND1 transcription start site. These experiments revealed the presence of multiple previously unrecognized, ionizing-radiation-enhanced ncRNAs (A, B, D and E) transcribed from multiple 59 regulatory regions of CCND1 (ncRNA CCND1 ; Fig. 4a ). TLS interacted with these ncRNA CCND1 s as detected by RNA immunoprecipitation assays ( Fig. 4b ; data not shown), and a ChIP assay revealed that TLS was recruited to these ncRNA CCND1 -'expressing' regions in an ionizingradiation-induced manner (Fig. 4c) . In contrast, TLS showed very weak interaction with ncRNA CCND1 -'non-expressing' regions C and F (Fig. 4c ). The level of TLS protein was never upregulated by ionizing irradiation, being either unchanged or, in some experiments, actually downregulated ( Supplementary Fig. 9c ).
Subcellular and chromatin fractionation studies revealed that ncRNA CCND1 was mainly bound to chromatin (Fig. 4d ). Real-time PCR analyses using several RNA species for which copy numbers have been well established as standards revealed that ncRNA CCND1 was present at a low copy number (for example, region D at about two copies per cell under basal conditions and about four copies per cell after treatment with ionizing radiation; Fig. 4e ). To test whether ncRNA CCND1 might be present, in part, as an RNA-DNA hybrid, we evaluated the effects of treatment with RNase H and found that this treatment partly diminished ncRNA CCND1 (Fig. 4f) . A portion of ncRNAs was also diminished by RNase T1, which digests singlestranded RNA. The combination of RNase H and RNase T1 caused a complete loss of ncRNAs (Fig. 4f ). This suggests that a portion of the ncRNA exists, at least transiently, as single-stranded RNA, in addition to a portion present as an RNA-DNA hybrid. TLS did not bind to the corresponding DNA sequence, nor did it bind to an RNA-DNA hybrid of the tested sequences ( Fig. 4g ; data not shown). ChIP for TLS on the CCND1 promoter was performed after digestion with RNase H or RNase T1, or both. As shown in Fig. 4h , RNase T1 blocked TLS recruitment, whereas treatment with RNase H had no inhibitory effect. These data argue against RNA-DNA hybrids serving as the landing pads for TLS. Our data also revealed the presence of bidirectional ncRNA transcripts, further induced by ionizing radiation ( Supplementary Fig. 10) ; in contrast, the adjacent 59 untranslated region (UTR) of CCND1 mRNA showed a decreased level in response to ionizing radiation ( Supplementary Fig. 10 ). RT, reverse transcriptase. Asterisk, P , 0.01; two asterisks, P , 0.002; n 5 6. b, Immunoprecipitation (IP) of TLS and detection of associated RNA by reverse transcription and real-time PCR. D, ncRNA CCND1 _D; 59UTR, 59 UTR of CCND1; transfer(t) RNA, tRNA14TyrATA. Asterisk, P , 0.01; n 5 3. c, ChIP of TLS on the ncRNA CCND1 -'expressing' (E, D and AB) and ncRNA CCND1 -'non-expressing' regions (F and C). Asterisk, P , 0.05; two asterisks, P , 0.01; n 5 3. CTL, control. d, Subcellular analysis of ncRNA CCND1 _D. e, Copy number of ncRNA CCND1 _D. f, Expression levels of ncRNA CCND1 _D on treatment with indicated RNases. Asterisk, P , 0.05; two asterisks, P , 0.001 compared with control, n 5 3. g, Gel-shift analysis of TLS interactions with RNA, complementary DNA or RNA:DNA hybrid (R:D). RNA, 2454s derived from ncRNA CCND1 _B. h, ChIP of TLS on the CCND1 promoter on treatment with the indicated RNases. Asterisk, P , 0.01 compared with control; n 5 3. Error bars indicate s.e.m.
Northern blotting analysis, with non-overlapped probes (about 200 nucleotides each) targeting the 59 regulatory regions of CCND1, showed species of about 330 and about 200 nucleotides, and larger transcripts ( Supplementary Fig. 11 ). The observations of clear variability in the lengths of these RNAs, and the fact that the bands were always multiple or diffuse, suggest diverse RNA polymerase II entry sites, or/and imprecise processing. ncRNA CCND1 proved to be regulated by RNA polymerase II and polyadenylated, but not capped ( Supplementary Fig. 12 ).
To investigate the potential function of ncRNA CCND1 , we identified specific siRNAs to the ncRNA CCND1 -'expressing' regions A (siA), D (siD) and E (siE); the ncRNA CCND1 -'non-expressing' regions C (siC) and F (siF); and the antisense 59 UTR of CCND1 (si59UTR). SiA specifically knocked down ncRNA CCND1 in region A without affecting that in region D; conversely, siD knocked down ncRNA CCND1 in region D but not in region A ( Supplementary Fig.  13 ), suggesting that multiple ncRNA transcripts were present, either as separate transcripts or as a result of rapid processing. Both strands of ncRNA CCND1 were targeted by siA or siD ( Supplementary Fig. 13 ). SiA, siD and siE (Fig. 5a, left) , but not siC, siF or si59UTR ( Supplementary Fig. 15a ), significantly enhanced the levels of endogenous CCND1 mRNA. In contrast, the expression of CCNE1 mRNA was not affected by either siA or siD (Fig. 5a, right) . Cotransfection with siA, siD and siE (siADE) showed similar effects on the CCND1 mRNA level compared with transfection with a single siRNA (Fig. 5a,  left) . As a control, the siRNA targeting the CCND1 coding region (siCCND1) specifically blocked CCND1 expression ( Fig. 5a, left) . These results argue against a trans-acting role for ncRNA CCND1 . SiD also enhanced the activity of CCND1 promoter-driven reporter containing the ncRNA CCND1 -'expressing' region ( Supplementary  Fig. 14) . In agreement with their putative local biological roles, siA or siD (Fig. 5b ), but not siC or siF ( Supplementary Fig. 15b ), caused a decrease in TLS recruitment to the CCND1 promoter at region A on treatment with ionizing radiation. In contrast, recruitment of p300 was unaffected by either siA or siD (Fig. 5b) . Similar data were observed in the absence of ionizing radiation (data not shown). Neither siA nor siD decreased the level of TLS protein ( Supplementary Fig. 15c ). These data suggest that ncRNA CCND1 s combinatorially or cooperatively cause repression of the CCND1 transcription unit.
Real-time PCR studies revealed the existence of ncRNA CCND1 s (D and A, but not C) in both high-molecular-mass and low-molecular-mass fractions ( Supplementary Fig. 16a ; data not shown). RNA oligonucleotides corresponding to the ncRNA CCND1 -'expressing' regions (for example 2454s and 2341a) were capable of binding to TLS and inhibiting the HAT function of p300 ( Fig. 5c and Supplementary Fig. 16b, c) . In contrast, a different series of RNA oligonucleotides evaluated, including oligonucleotides based on the b-actin mRNA sequence and the ncRNA CCND1 -'non-expressing' region C (2764a), were unable to bind to TLS ( Supplementary Fig.  16d ) or inhibit the HAT functions of p300 (Fig. 5c ). Moreover, siA and siD, but not siC or siF, resulted in an increase in histone acetylation (AcH3-K9K14) on the CCND1 promoter ( Fig. 5d) .
We suggest a model in which ncRNAs serve as molecular 'ligands' for a specific RNA-binding protein, namely TLS, causing an allosteric effect to release it from an inactive conformation. This in turn permits gene-specific TLS-CBP/p300 interactions resulting in the inhibition of HAT functions of CBP and p300 and the repression of transcription (Fig. 5e ). It is tempting to speculate that other RNAbinding co-regulators exert functional roles on gene transcription by being analogously recruited to the transcription units through genespecific ncRNAs.
METHODS SUMMARY
RAW264.7 and HeLa cells were maintained in DMEM (Gibco) supplemented with 10% fetal calf serum (FCS; Gemini). Plasmids and siRNAs were transfected with Lipofectamine 2000 (Invitrogen) as directed. Specific antibodies were obtained from BD Biosciences (anti-TLS), Santa Cruz Biotechnology (anti-CBP and anti-p300) and Millipore (anti-acetylated histone H3). recruiting TLS to the CCND1 promoter. a, Expression levels of CCND1 and CCNE1 in the presence of siRNA targeting ncRNA CCND1 _A (siA), ncRNA CCND1 _D (siD) or ncRNA CCND1 _E (siE), or by cotransfection with these siRNAs (siADE), or targeting the CCND1-coding region (siCCND1). Asterisk, P , 0.01 compared with control siRNA (siCTL); n 5 6. b, ChIP of TLS and p300 on the CCND1 promoter in the presence of siA or siD on treatment with ionizing radiation. c, RNA oligonucleotides tested for TLS binding and p300 HAT inhibition. d, ChIP of AcH3-K9K14 on the CCND1 promoter in the presence of indicated siRNAs. Asterisk, P , 0.05; n 5 3. Error bars in a, b and d indicate s.e.m. e, Model. 
